Papulopustular Rosacea Treatment By Ivermectin

  • Published: Oct 11, 2017
  • Family: 40
  • Cited scholarly works: 0
  • Cited by: 0
  • Cites: 3
  • Additional Info:
Full-text?

The full document isn't yet available to us from the patent office, but we've found a related patent (family member) to use for our images and PDF.

Abstract

FIELD: pharmacology.SUBSTANCE: invention is a method for treatment of papulopustular rosacea in a subject in need thereof, comprising topical application of a therapeutically effective amount of a pharmaceutical composition comprising ivermectin and a pharmaceutically acceptable carrier, once a day, to a region of skin afflicted with papulopustular rosacea, wherein the treatment results in a significant reduction in the number of inflammatory foci within 2 weeks after the initial application of the pharmaceutical composition.EFFECT: significant reduction in the number of inflammatory foci two weeks after the initial application without joint application of another active agent, more effective treatment, and a longer remission, a reduction in adverse skin reactions.16 cl, 12 dwg, 7 tbl, 4 ex


Claims

Information currently unavailable.

CPC Classifications
Family Member PDF
Family Member Preview
These are the images from a related family member, as the full document isn't yet available to us from the patent office.
Document History
  • Publication: Oct 11, 2017
  • Application: Jul 8, 2014
    RU RU 2016103715 A
  • Priority: Jul 8, 2014
    US US 2014/0045739 W
  • Priority: Mar 13, 2014
    US US 201414209958 A
  • Priority: Jan 15, 2014
    US US 201461927717 P
  • Priority: Dec 20, 2013
    US US 201361919208 P
  • Priority: Jul 8, 2013
    US US 201361843540 P

Sign in to the Lens